Supplemental Experimental Procedures
RNA extraction, probe synthesis and hybridization on oligonucleotide arrays of tumour samples .
Total RNA from breast tumour samples was isolated using TRIZOL reagent (Life Technologies) and RNaesy Extraction Kit (QIAGen) as indicated by the manufacturer.
Purity of isolated RNA was evaluated spectrophotometrically by the A260/A280 absorbance ratio. Microarray experiments were performed using Human Whole Genome V2 4*44K array G4845A (Agilent technologies). RNA was labelled and array hybridized using the Low RNA Linear Amplification Kit and the In Situ Hybridization Kit Plus (Agilent technologies), respectively, following manufacturer's protocol. After hybridization and washing, the slides were scanned in an Axon GenePix Scanner (Axon Instruments) and analyzed using Feature Extraction Software 10.0 (Agilent technologies). RNA samples from independent tumours were labelled with Cy5-dUTP and as control a pooled RNA obtained from equal concentration of each RNA tumor sample labelled with Cy3-dUTP was used. A hierarchical clustering method was applied to group the genes and samples on the basis of the similarities in expression and the unsupervised analyses were visualized using the SOTA and TreeView software assuming euclidean distances between genes (http://bioinfo.cnio.es/cgibin/tools/clustering/sotarray). Genes with potentially significant changes in expression were identified using the POMELO program (http://www.genoma.wi.mit.edu/MPR/software). We tested the null hypothesis of equal means among groups using T-test, computing p-values using a permutation test.
To select differentially expressed genes, we adjusted for multiple testing using the 
Western blot
Protein from whole cell extracts (30-50 g) were analysed by Western blot as previously described (Moreno-Bueno et al. 2009) using the antibodies indicated in Table S4 and ECL detection system (GE Healthcare).
Immunofluorescence and confocal analyses
Inmunofluorescence analysis was performed on cell grown on coverslips and fixed under conditions for antibodies and fixation procedures described in Table S4 .
Secondary antibodies were anti-mouse or anti-rabbit Alexa 488/546, depending on the primary antibodies. Phalloidin-647 (Amersham) was used to stain F-actin. Confocal microscopy analyses were performed using a Leica Spectral TCS SP2, x63 objective.
Maximal projections were obtained for x-y planes; for z-x planes a z level color coded projection was used to show the position of membrane structures in the different sections.
Generation of ΔLOXL2 (mutant catalytic domain) vector
The LOXL2 mutant carries a deleted region from amino acids 548 to 688 (nt positions 
Promoter assays
Cotransfections were carried out in the presence of the 50 ng of Snail1, LOXL2 or ΔLOXL2 cDNAs (or the indicated amounts of LOXL2 cDNA) and 200 ng of the indicated promoters and 10 ng of β-gal as control of transfection efficiency. The amount of total DNA was normalized with empty pcDNA3 vector (up to 100 ng). Luciferase and β-galactosidase activities were measured using the luciferare and β-Glo assay substrates (Promega) and normalized to the wild-type promoter activity detected in cells transfected with pcDNA3 empty vector or in wild-type cells.
Barrier assays
Barrier assay was performed as described (Van Horssen et al, 2006) . Basically, cells
were grown on coverslips to confluence and then the coverslips were transferred to a new culture plate with fresh medium and photographed at different time points.
Invasion assays
Invasion of the indicated cell lines on modified Boyden chambers (8 m pore filters) coated with 100 g/ml collagen type IV gel were performed as previously described 
Proliferation assays
To study the proliferation index, 2.5x10 4 cells were grown into 96-wells plate according to Cell Proliferation ELISA, BrdU (colorimetric) kit, (Roche Diagnostic SL, Basel, Switzerland) using the manufacturer's recommended conditions.
Metanalysis
For validation of the metastatic prediction model, several independent dataset of breast Supplemental Tables. Supplemental Table S2 
Unsupervised analysis
Unsupervised analysis using Basal Breast Signature (BBS) in public databases n=311
